Table 4.
Characterisitics | Stable disease group (n = 37) |
Progress disease group (n = 6) |
P |
---|---|---|---|
Age | 58.0 ± 11.8 | 70.7 ± 11.6 | 0.019 |
Gender, n (%) | 0.164 | ||
Male | 8 (17.6%) | 3 (44.4%) | |
Female | 29 (82.4%) | 3 (55.6%) | |
Tumor location, n (%) | |||
Cardia | 6 (16.2%) | 0 | 0.571 |
Fundus | 25 (67.6%) | 2 (33.3%) | 0.174 |
Body | 6 (16.2%) | 4 (66.7%) | 0.020 |
Antrum | 0 | 0 | 1.000 |
Initial diameter (mm) | 8.14 ± 3.10 | 13.83 ± 4.83 | 0.033 |
Initial EUS, n (%) | 1.000 | ||
Low risk | 35 (94.6%) | 6 (100%) | |
High risk | 2 (5.4%) | 0 | |
F/u EUS, n (%) | 0.007 | ||
Low risk | 33 (89.2%) | 2 (33.3%) | |
High risk | 4 (10.8%) | 4 (66.7%) | |
Growth rate per year (%) | −0.8 ± 5.4 | 37.3 ± 22.1 | 0.008 |